Artemisinin was first discovered by Tu Youou in 1972 in the leaves of Artemisia annua. Subsequently, pure artemisinin was obtained by biosynthesis. Artemisinin works by means of free radicals activated in the presence of iron. Initially Artemisinin was used to treat cases of malaria infections. Subsequently, numerous other therapeutic actions of this compound have been discovered.
Richard Schlegel et al., even obtained an invention patent No. US20120010278 A1 with the title: Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections.
Cancer
Studies conducted by Lai H. “Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds” and by Nakas I. “Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation” have led to the conclusion that artemisinin and its derivatives react with iron forming compounds that can kill malignant cells. Cancer cells are much more susceptible to the cytotoxic effect of artemisinim versus healthy cells because cancer cells have more transfer receptors facilitating the accumulation of iron-rich proteins. Artemisinin is also accumulated by cancer cells. When in contact with the iron, artemisinin generates free radicals within the cancer cell that gets destroyed.
Studies by Dr. Lam show that artemisinin is effective against a wide range of cancers. The most effective one is in leukemia and colon cancer. But it also has good efficiency in melanoma, breast, ovarian, prostate, liver and kidney cancer.
Parasites
Parasites accumulate iron infecting red cells that are rich in iron. An excess of iron can activate artemisinin that generates a burst of free radicals that attack red cells with excess iron, thus destroying parasites as well.
Artemisinin has proven to be effective when integrated into Borellia protocols (Lyme disease) (Alternative Medicine Townssend Letter, April 2011).
According to the recent issue of the scientific journal “Int. J. Pharm. Sci. Rev. Res., 32 (1), May – June 2015″Artemisinin acts against fungal infections including candidiasis, either alone or in combination with other antifungals (eg. Goldenseal and / or Pau d’Arco).
Antiviral (broad-spectrum)
Researchers at Heidelberg’s Pharmaceutical Biology Center, published in 2008 in the journal Clinical Infectious Diseases, titled “The Antiviral Activities of Artemisinin and Artesunate”, concluded that artemisinin has a strong anti-viral activity against: cytomegalovirus and other Herpesviruses (eg. herpes simplex virus type 1 and Epstein-Barr virus), hepatitis B virus, hepatitis C virus. Artemisinin also stops the replication of hepatitis B and C viruses.
More recently, in 2014 Goodrich et al., in the review article “The use of artemisinin and its derivatives to treat HPV-infected/ transformed cells and cervical cancer review” concluded that artemisinin is active against Papiloma virus infections and against atypical or already transformed cervical cancer cells.
The presence of iron or an iron donor such as hemin increases the antiviral potency of artemisinin according to Paeshuyse J. et al. in the article “Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin” published in Biochem Biophys Res Commun. 2006
For cancer it is synergistically associated with Ferivit: 1 capsule together with 1000 mg of Vitamin C. It will be administered immediately after the evening meal.
Ingredients / capsule:
Artemisinin (obtained by biosynthesis of beer dough – Saccharomyces cerevisiae) |
100 mg |
Magnesium stearate (anti-caking agent) |
5 mg |
Vegetable capsule hypromellose |
76 mg |
Microcrystalline cellulose (loading agent) |
155 mg |
It does not contain: dairy products, eggs, gluten, wheat, corn, soy, nuts, ferments, artificial sweeteners, flavors or dyes.
The recommended way of use (only for adults): 1 capsule per day, on an empty stomach or as your doctor recommends.